• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Is my paper relevant for an international audience?我的论文对国际读者有相关性吗?
Pharm Pract (Granada). 2020 Apr-Jun;18(2):1924. doi: 10.18549/PharmPract.2020.2.1924. Epub 2020 Apr 29.
2
How to convince an editor to accept your paper quickly.如何快速说服编辑接受你的论文。
Sci Total Environ. 2021 Dec 1;798:149243. doi: 10.1016/j.scitotenv.2021.149243. Epub 2021 Jul 22.
3
How to get your paper published.
J Thorac Cardiovasc Surg. 2001 Apr;121(4 Suppl):S3-7. doi: 10.1067/mtc.2001.114493.
4
From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.克罗地亚皮肤性病学会史——克罗地亚医学协会及《克罗地亚皮肤性病学学报》重要信息概述
Acta Dermatovenerol Croat. 2018 Dec;26(4):344-348.
5
Procedures and methods of benefit assessments for medicines in Germany.德国药品效益评估的程序和方法。
Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.
6
[Procedures and methods of benefit assessments for medicines in Germany].[德国药品效益评估的程序和方法]
Dtsch Med Wochenschr. 2008 Dec;133 Suppl 7:S225-46. doi: 10.1055/s-0028-1100954. Epub 2008 Nov 25.
7
The inaugural Qatar Critical Care Conference with its Qatar Medical Journal Special Issue - An important milestone.首届卡塔尔重症监护会议及其《卡塔尔医学杂志》特刊——一个重要的里程碑。
Qatar Med J. 2019 Nov 7;2019(2):1. doi: 10.5339/qmj.2019.qccc.1. eCollection 2019.
8
Rules to be adopted for publishing a scientific paper.发表科学论文应采用的规则。
Ann Ital Chir. 2016;87:1-3.
9
Peer review at the Health Information and Libraries Journal.《健康信息与图书馆杂志》的同行评审
Health Info Libr J. 2014 Dec;31(4):251-3. doi: 10.1111/hir.12089.
10
Successful publishing: how to get your paper accepted.成功发表:如何让你的论文被录用。
Surg Oncol. 2009 Dec;18(4):350-6. doi: 10.1016/j.suronc.2008.09.001. Epub 2008 Oct 11.

引用本文的文献

1
Authors, peer reviewers, and readers: What is expected from each player in collaborative publishing?作者、同行评审人员和读者:合作出版中对每个参与者有何期望?
Pharm Pract (Granada). 2021 Jan-Mar;19(1):2284. doi: 10.18549/PharmPract.2021.1.2284. Epub 2021 Jan 14.

本文引用的文献

1
Do pharmacy intervention reports adequately describe their interventions? A template for intervention description and replication analysis of reports included in a systematic review.药学干预报告是否充分描述了其干预措施?系统评价中纳入报告的干预描述和重复分析模板。
BMJ Open. 2019 Dec 19;9(12):e025511. doi: 10.1136/bmjopen-2018-025511.
2
PaCIR: A tool to enhance pharmacist patient care intervention reporting.PaCIR:增强药剂师患者护理干预报告的工具。
J Am Pharm Assoc (2003). 2019 Sep-Oct;59(5):615-623. doi: 10.1016/j.japh.2019.07.008. Epub 2019 Aug 7.
3
Why Is It so Hard to Do Good Science?为什么做好科学研究如此之难?
eNeuro. 2018 Sep 6;5(5). doi: 10.1523/ENEURO.0188-18.2018. eCollection 2018 Sep-Oct.
4
Data reviews quick to produce but open to abuse.数据审查很快就能完成,但容易被滥用。
Nature. 2018 May;557(7703):31. doi: 10.1038/d41586-018-05006-2.
5
The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta-analyses.冗余、误导性及存在冲突的系统评价和Meta分析的大量产出。
Milbank Q. 2016 Sep;94(3):485-514. doi: 10.1111/1468-0009.12210.
6
Pharmacists' interventions on clinical asthma outcomes: a systematic review.药师干预对临床哮喘结局的影响:系统评价。
Eur Respir J. 2016 Apr;47(4):1134-43. doi: 10.1183/13993003.01497-2015. Epub 2015 Dec 17.
7
Ensuring consistent reporting of clinical pharmacy services to enhance reproducibility in practice: an improved version of DEPICT.确保临床药学服务报告的一致性以提高实践中的可重复性:DEPICT的改进版本。
J Eval Clin Pract. 2015 Aug;21(4):584-90. doi: 10.1111/jep.12339. Epub 2015 Feb 12.
8
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.Cochrane 协作网评估随机试验偏倚风险的工具。
BMJ. 2011 Oct 18;343:d5928. doi: 10.1136/bmj.d5928.
9
The role and interpretation of pilot studies in clinical research.初步研究在临床研究中的作用和解释。
J Psychiatr Res. 2011 May;45(5):626-9. doi: 10.1016/j.jpsychires.2010.10.008. Epub 2010 Oct 28.
10
What is a pilot or feasibility study? A review of current practice and editorial policy.什么是试点或可行性研究?对当前实践和社论政策的回顾。
BMC Med Res Methodol. 2010 Jul 16;10:67. doi: 10.1186/1471-2288-10-67.

我的论文对国际读者有相关性吗?

Is my paper relevant for an international audience?

作者信息

Fernandez-Llimos Fernando

机构信息

PhD, MPharm, MBA. Editor-in-chief, Pharmacy Practice. Laboratory of Pharmacology, Department of Drug Sciences, College of Pharmacy, University of Porto. Porto (Portugal)

出版信息

Pharm Pract (Granada). 2020 Apr-Jun;18(2):1924. doi: 10.18549/PharmPract.2020.2.1924. Epub 2020 Apr 29.

DOI:10.18549/PharmPract.2020.2.1924
PMID:32377281
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7190395/
Abstract

This is the first question one should consider before submitting a paper to an international journal. The answer is simple: If researchers or practitioners from another country can learn something from your paper that can influence a practice or a research they are involved in, then your paper is relevant for an international audience. There are many elements that can influence in this cross-border transferability. One could think that having a big "n", or performing complex statistical calculations, or using complicated study designs makes the paper more attractive to colleagues from other countries. These elements can help, but they are not sufficient. On the other hand, one could think that a study performed in a small hospital in a given country will never be of interest for these foreign colleagues. That is not necessarily correct. Let's burst some myths.

摘要

这是在向国际期刊提交论文之前人们应该考虑的第一个问题。答案很简单:如果来自其他国家的研究人员或从业者能够从你的论文中学到一些可以影响他们所参与的实践或研究的东西,那么你的论文就与国际读者相关。有许多因素会影响这种跨境可转移性。有人可能认为拥有大量样本量、进行复杂的统计计算或使用复杂的研究设计会使论文对其他国家的同行更具吸引力。这些因素会有所帮助,但并不足够。另一方面,有人可能认为在某个特定国家的一家小医院进行的研究永远不会引起这些外国同行的兴趣。这不一定正确。让我们打破一些误区。